BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
4.000
0.00 (0.00%)
At close: Jul 18, 2025

BHIC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
0.890.09-0.25-0.17-0.01
Stock-Based Compensation
---00.01
Change in Accounts Receivable
-0.03-0.06-0.03-0.01-
Change in Inventory
-0.72-0.02-0.03-0.01-
Change in Accounts Payable
00-0.01--
Change in Unearned Revenue
0.110.020--
Change in Other Net Operating Assets
-0.03-0000
Operating Cash Flow
0.220.02-0.31-0.180
Sale (Purchase) of Intangibles
-0.07-0.03---
Investing Cash Flow
-0.07-0.03---
Short-Term Debt Issued
-0.960.610.18-
Total Debt Issued
2.690.960.610.18-
Short-Term Debt Repaid
--1.07-0.57-0.13-
Total Debt Repaid
-2.5-1.07-0.57-0.13-
Net Debt Issued (Repaid)
0.19-0.110.040.04-
Issuance of Common Stock
0.460.760.270.15-
Other Financing Activities
--0.01--
Financing Cash Flow
0.650.650.320.19-
Net Cash Flow
0.810.640.010.010
Levered Free Cash Flow
-0.17-0.06-0.2-0.08-
Unlevered Free Cash Flow
-0.17-0.06-0.2-0.08-
Change in Working Capital
-0.66-0.06-0.06-0.020
Source: S&P Global Market Intelligence. Standard template. Financial Sources.